Wide Ranks

BRKR

Bruker Corporation

58.38

Top Statistics
Market Cap 8 B Forward PE 21.21 Revenue Growth 16.40 %
Current Ratio 1.66 Trailing PE 28.20 Earnings Growth -55.00 %
Profit Margins 9.41 % Peg Ratio Dividend Yield 0.34 %
Enterprice / EBITA 20.25 Enterprise / Revenue 3.45 Price To Sales Trailing12 Months 2.73
Profitability
Profit Margins 9.41 % Operating Margins 9.99 %
Balance Sheet
Total Cash 157 M Total Cash Per Share 1.04 Total Debt 2 B
Total Debt To Equity 132.63 Current Ratio 1.66 Book Value Per Share 11.92
All Measures
Short Ratio 204.00 % Message Board Id finmb_527317 Fax 978 663 5585
Shares Short Prior Month 4 M Return On Equity 0.1973 City Billerica
Uuid ab422d97-7e2c-351a-832e-83c073c93091 Previous Close 57.50 First Trade Date Epoch Utc 965 M
Book Value 11.92 Beta 1.20 Total Debt 2 B
Volume 1 M Price To Book 4.90 Fifty Two Week Low 48.07
Total Cash Per Share 1.04 Total Revenue 3 B Shares Short Previous Month Date 1 B
Target Median Price 75.00 Max Age 86400 Recommendation Mean 1.92
Sand P52 Week Change 0.3133 Operating Margins 9.99 % Last Dividend Value 0.0500
Target Mean Price 74.74 Net Income To Common 304 M Short Percent Of Float 0.0272
Implied Shares Outstanding 151 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 2 M Average Volume10days 2 M Total Cash 157 M
Next Fiscal Year End 1 B Revenue Per Share 21.98 Held Percent Insiders 0.3191
Ebitda Margins 17.03 % Dividend Rate 0.2000 Trailing PE 28.20
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 57.50
Target Low Price 60.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 61.02
Open 57.56 Dividend Yield 0.34 % State MA
Free Cashflow 249 M Return On Assets 0.0483 Time Zone Short Name EST
Trailing Eps 2.07 Day Low 57.56 Address1 40 Manning Road
Trailing Annual Dividend Rate 0.2000 Price Hint 2 Shares Outstanding 151 M
Target High Price 85.00 Website https://www.bruker.com 52 Week Change -0.1031
Average Volume 1 M Earnings Quarterly Growth -53.60 % Forward Eps 2.71
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 65.80 %
Is_sp_500 False Regular Market Day High 59.00 Profit Margins 9.41 %
Debt To Equity 132.63 Fifty Two Week High 94.86 Day High 59.00
Shares Short 3 M Regular Market Open 57.56 Industry Key medical-devices
Earnings Growth -55.00 % Enterprise To Revenue 3.45 Revenue Growth 16.40 %
Shares Percent Shares Out 0.0199 Operating Cashflow 266 M Five Year Avg Dividend Yield 29.00 %
Currency USD Market Cap 8 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 01821 Payout Ratio 9.66 %
Quote Type EQUITY Industry Medical Devices Ex Dividend Date 1 B
Regular Market Day Low 57.56 Held Percent Institutions 0.7972 Long Name Bruker Corporation
Current Price 58.38 Enterprise To Ebitda 20.25 Financial Currency USD
Trailing Annual Dividend Yield 0.35 % Current Ratio 1.66 Gross Margins 49.95 %
Industry Disp Medical Devices Number Of Analyst Opinions 11 Country United States
Float Shares 103 M Two Hundred Day Average 70.68 Ir Website http://ir.bruker.com/phoenix.zhtml?c=121496&p=irol-IRHome
Enterprise Value 11 B Price To Sales Trailing12 Months 2.73 Forward PE 21.21
Regular Market Volume 1 M Last Dividend Date 1 B Ebitda 551 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.

It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.

In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.

The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.